To preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants, and for other purposes.

HR9830, titled 'To preserve lawful hemp commerce while protecting consumers from high-THC synthetic intoxicants, and for other purposes,' was introduced in the House on July 22, 2026, by Rep. Andy Barr (R-KY-6) with one original cosponsor, Rep. Angie Craig (D-MN-2). The bill has been referred to the Committees on Ways and Means, Energy and Commerce, Agriculture, and Transportation and Infrastructure for consideration of relevant provisions. This broad referral indicates the bill touches on multiple policy domains, including tax (Ways and Means), consumer safety (Energy and Commerce), agricultural production (Agriculture), and potentially transportation of goods (Transportation and Infrastructure).

The bill is in the earliest legislative stage—introduced and referred to committee. No committee hearings, markups, or reports have occurred. The bill does not authorize or appropriate any specific funding amount; it is a regulatory measure. The title suggests it seeks to clarify the legal distinction between lawful hemp (low THC) and synthetic high-THC intoxicants, likely to protect the legitimate hemp/CBD industry from competition with unregulated synthetic cannabinoids. However, without the full bill text, the precise mechanisms (e.g., definitions, penalties, labeling requirements) remain unknown.

No related signals or presidential actions directly converge with this bill. The recent presidential proclamations on chemical manufacturing regulatory relief and Bears Ears National Monument address different policy domains (manufacturing compliance costs and land use for energy/mining) and do not share a specific objective or technology class with hemp regulation.

Given the early stage and lack of detail, there is no identifiable market impact at this time. Investors should monitor committee activity, particularly in the Agriculture and Energy and Commerce committees, for further developments. The bill's progress will depend on hearings, amendments, and potential markup. If the bill advances, it could affect companies in the hemp/CBD sector by clarifying regulatory boundaries, but currently no specific tickers can be reliably linked.